Product Information
VENLAFAXINE HCL ER 37.5 MG CAP is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0795 per EA under NDC 31722000230. Its NADAC has been published 302 times since Nov 11, 2020.
FDA first approved this application on Jul 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722000230
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212277FDA Approved
7/8/2019
TE Code
AB
On Market Since
7/8/2019
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has been published 302 times since Nov 11, 2020, and over the history we have for it it has declined 35.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0795 per EA |
|---|---|
| All-time high | $0.1357 (Feb 10, 2021) |
| All-time low | $0.0712 (Nov 20, 2024) |
| 52-week high | $0.0924 |
| 52-week low | $0.0795 |
| Median price | $0.0989 |
| Average price | $0.1018 |
| Largest weekly change | +28.7% (Aug 21, 2024) |
| Weeks tracked | 302 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG CAP, manufactured by Camber Pharmaceuticals Inc., is $0.0795 per EA (NDC 31722000230), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL ER 37.5 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has declined 35.0%. It has been tracked across 302 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG CAP?
Since Nov 11, 2020, the NADAC for VENLAFAXINE HCL ER 37.5 MG CAP has ranged from a low of $0.0712 (Nov 20, 2024) to a high of $0.1357 (Feb 10, 2021), with a median of $0.0989 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG CAP?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 37.5 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 37.5 MG CAP?
VENLAFAXINE HCL ER 37.5 MG CAP (NDC 31722000230) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.